Image of Fondaparinux in Acute Coronary Syndromes

LITERATURE

Fondaparinux in Acute Coronary Syndromes


Anticoagulant therapy is a major component in the management of acute coronary syndromes (ACS). Anticoagulant-associated adverse events like heparin-induced thrombocytopenia, bleeding complications and need of close monitoring of anticoagulation led to focus on developing agents causing anticoagulation without affecting primary haemostasis.
Fondaparinux, a new-age synthetic anticoagulant, acts by inhibiting
factor Xa. It is simple to administer and has low inter and intra-subject
variability.


Availability

Diviti-001Titan CenterAvailable

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Journal of The Association of Physicians of India ■ Vol. 63 ■ July 2015
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous